APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucose Dependent Insulinotropic Receptor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glucose Dependent Insulinotropic Receptor Industry Growth and Trends Forecast to 2032

19 December 2025100 pages

Choose your research edition.

Industry ResearchGlucose Dependent Insulinotropic Receptor Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucose Dependent Insulinotropic Receptor Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Glucose Dependent Insulinotropic Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucose Dependent Insulinotropic Receptor Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucose Dependent Insulinotropic Receptor Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

According to APO Research, the global Glucose Dependent Insulinotropic Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glucose Dependent Insulinotropic Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glucose Dependent Insulinotropic Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucose Dependent Insulinotropic Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Glucose Dependent Insulinotropic Receptor market include Takeda Pharmaceutical Co Ltd, Novartis AG, Merck & Co Inc, GlaxoSmithKline Plc, Amgen Inc, Yuhan Corp, Taisho Pharmaceutical Holdings Co Ltd, Kowa Co Ltd and Hyundai Pharmaceutical Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glucose Dependent Insulinotropic Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glucose Dependent Insulinotropic Receptor market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glucose Dependent Insulinotropic Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glucose Dependent Insulinotropic Receptor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Glucose Dependent Insulinotropic Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glucose Dependent Insulinotropic Receptor Market by Company

Takeda Pharmaceutical Co Ltd

Novartis AG

Merck & Co Inc

GlaxoSmithKline Plc

Amgen Inc

Yuhan Corp

Taisho Pharmaceutical Holdings Co Ltd

Kowa Co Ltd

Hyundai Pharmaceutical Co Ltd

F. Hoffmann-La Roche Ltd

Dong-A Socio Holdings Co Ltd

CymaBay Therapeutics Inc

Arena Pharmaceuticals Inc

Glucose Dependent Insulinotropic Receptor Segment by Type

MBX-2982

HOB-047

HD-0471953

HD-0471042

GSK-2041706

DA-1241

Others

Glucose Dependent Insulinotropic Receptor Segment by Application

Type 2 Diabetes

Obesity

Chronic Obstructive Pulmonary Disease (COPD)

Dyslipidemia

Others

Glucose Dependent Insulinotropic Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucose Dependent Insulinotropic Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucose Dependent Insulinotropic Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucose Dependent Insulinotropic Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Glucose Dependent Insulinotropic Receptor companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Glucose Dependent Insulinotropic Receptor Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Glucose Dependent Insulinotropic Receptor Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Glucose Dependent Insulinotropic Receptor Market Share by Region (2021-2026) Table 4. Global Glucose Dependent Insulinotropic Receptor Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Glucose Dependent Insulinotropic Receptor Market Share by Region (2027-2032) Table 6. Global Glucose Dependent Insulinotropic Receptor Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Glucose Dependent Insulinotropic Receptor Market Size Share by Type (2021-2026) Table 9. Global Glucose Dependent Insulinotropic Receptor Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Glucose Dependent Insulinotropic Receptor Market Size Share Forecasted by Type (2027-2032) Table 11. North America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Glucose Dependent Insulinotropic Receptor Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Glucose Dependent Insulinotropic Receptor Market Size Share by Application (2021-2026) Table 24. Global Glucose Dependent Insulinotropic Receptor Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Glucose Dependent Insulinotropic Receptor Market Size Share Forecasted by Application (2027-2032) Table 26. North America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Glucose Dependent Insulinotropic Receptor Industry Trends Table 37. Glucose Dependent Insulinotropic Receptor Industry Drivers Table 38. Glucose Dependent Insulinotropic Receptor Industry Opportunities and Challenges Table 39. Glucose Dependent Insulinotropic Receptor Industry Restraints Table 40. Global Glucose Dependent Insulinotropic Receptor Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Company (2021-2026) Table 42. Global Glucose Dependent Insulinotropic Receptor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Glucose Dependent Insulinotropic Receptor Key Company Headquarters & Area Served Table 44. Global Glucose Dependent Insulinotropic Receptor Company, Product Type & Application Table 45. Global Glucose Dependent Insulinotropic Receptor Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Glucose Dependent Insulinotropic Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Pharmaceutical Co Ltd Company Information Table 49. Takeda Pharmaceutical Co Ltd Business Overview Table 50. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 52. Takeda Pharmaceutical Co Ltd Recent Development Table 53. Novartis AG Company Information Table 54. Novartis AG Business Overview Table 55. Novartis AG Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis AG Glucose Dependent Insulinotropic Receptor Product Portfolio Table 57. Novartis AG Recent Development Table 58. Merck & Co Inc Company Information Table 59. Merck & Co Inc Business Overview Table 60. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 62. Merck & Co Inc Recent Development Table 63. GlaxoSmithKline Plc Company Information Table 64. GlaxoSmithKline Plc Business Overview Table 65. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 67. GlaxoSmithKline Plc Recent Development Table 68. Amgen Inc Company Information Table 69. Amgen Inc Business Overview Table 70. Amgen Inc Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Amgen Inc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 72. Amgen Inc Recent Development Table 73. Yuhan Corp Company Information Table 74. Yuhan Corp Business Overview Table 75. Yuhan Corp Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Yuhan Corp Glucose Dependent Insulinotropic Receptor Product Portfolio Table 77. Yuhan Corp Recent Development Table 78. Taisho Pharmaceutical Holdings Co Ltd Company Information Table 79. Taisho Pharmaceutical Holdings Co Ltd Business Overview Table 80. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 82. Taisho Pharmaceutical Holdings Co Ltd Recent Development Table 83. Kowa Co Ltd Company Information Table 84. Kowa Co Ltd Business Overview Table 85. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 87. Kowa Co Ltd Recent Development Table 88. Hyundai Pharmaceutical Co Ltd Company Information Table 89. Hyundai Pharmaceutical Co Ltd Business Overview Table 90. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 92. Hyundai Pharmaceutical Co Ltd Recent Development Table 93. F. Hoffmann-La Roche Ltd Company Information Table 94. F. Hoffmann-La Roche Ltd Business Overview Table 95. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 97. F. Hoffmann-La Roche Ltd Recent Development Table 98. Dong-A Socio Holdings Co Ltd Company Information Table 99. Dong-A Socio Holdings Co Ltd Business Overview Table 100. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 102. Dong-A Socio Holdings Co Ltd Recent Development Table 103. CymaBay Therapeutics Inc Company Information Table 104. CymaBay Therapeutics Inc Business Overview Table 105. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 107. CymaBay Therapeutics Inc Recent Development Table 108. Arena Pharmaceuticals Inc Company Information Table 109. Arena Pharmaceuticals Inc Business Overview Table 110. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 112. Arena Pharmaceuticals Inc Recent Development Table 113. North America Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2026) Table 116. North America Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Glucose Dependent Insulinotropic Receptor Market Share Forecast by Country (2027-2032) Table 118. Europe Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2026) Table 121. Europe Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Glucose Dependent Insulinotropic Receptor Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2026) Table 126. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Share Forecast by Country (2027-2032) Table 128. Latin America Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2026) Table 131. Latin America Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Glucose Dependent Insulinotropic Receptor Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2026) Table 136. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Glucose Dependent Insulinotropic Receptor Product Image Figure 3. Global Glucose Dependent Insulinotropic Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 5. Global Glucose Dependent Insulinotropic Receptor Market Share by Region: 2025 VS 2032 Figure 6. Global Glucose Dependent Insulinotropic Receptor Market Share by Region (2021-2032) Figure 7. North America Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. MBX-2982 Image Figure 13. Global MBX-2982 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. HOB-047 Image Figure 15. Global HOB-047 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. HD-0471953 Image Figure 17. Global HD-0471953 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. HD-0471042 Image Figure 19. Global HD-0471042 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. GSK-2041706 Image Figure 21. Global GSK-2041706 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. DA-1241 Image Figure 23. Global DA-1241 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Others Image Figure 25. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Global Glucose Dependent Insulinotropic Receptor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 27. Global Glucose Dependent Insulinotropic Receptor Market Share by Type 2025 VS 2032 Figure 28. North America Glucose Dependent Insulinotropic Receptor Market Size Share by Type (2021-2032) Figure 29. Europe Glucose Dependent Insulinotropic Receptor Market Size Share by Type (2021-2032) Figure 30. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Share by Type (2021-2032) Figure 31. Latin America Glucose Dependent Insulinotropic Receptor Market Size Share by Type (2021-2032) Figure 32. Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size Share by Type (2021-2032) Figure 33. Type 2 Diabetes Image Figure 34. Global Type 2 Diabetes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Obesity Image Figure 36. Global Obesity Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 38. Global Chronic Obstructive Pulmonary Disease (COPD) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Dyslipidemia Image Figure 40. Global Dyslipidemia Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Others Image Figure 42. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Global Glucose Dependent Insulinotropic Receptor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Glucose Dependent Insulinotropic Receptor Market Share by Application 2025 VS 2032 Figure 45. North America Glucose Dependent Insulinotropic Receptor Market Size Share by Application (2021-2032) Figure 46. Europe Glucose Dependent Insulinotropic Receptor Market Size Share by Application (2021-2032) Figure 47. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Share by Application (2021-2032) Figure 48. Latin America Glucose Dependent Insulinotropic Receptor Market Size Share by Application (2021-2032) Figure 49. Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size Share by Application (2021-2032) Figure 50. Global Top 5 and 10 Glucose Dependent Insulinotropic Receptor Players Market Share by Revenue in 2025 Figure 51. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 52. North America Glucose Dependent Insulinotropic Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. North America Glucose Dependent Insulinotropic Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. North America Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032) Figure 55. Europe Glucose Dependent Insulinotropic Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Glucose Dependent Insulinotropic Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032) Figure 58. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032) Figure 61. Latin America Glucose Dependent Insulinotropic Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Glucose Dependent Insulinotropic Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032) Figure 64. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 65. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 66. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032) Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • MBX-2982
  • HOB-047
  • HD-0471953
  • HD-0471042
  • GSK-2041706
  • DA-1241
  • Others
Applications
  • Type 2 Diabetes
  • Obesity
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Dyslipidemia
  • Others
Companies covered
  • Takeda Pharmaceutical Co Ltd
  • Novartis AG
  • Merck & Co Inc
  • GlaxoSmithKline Plc
  • Amgen Inc
  • Yuhan Corp
  • Taisho Pharmaceutical Holdings Co Ltd
  • Kowa Co Ltd
  • Hyundai Pharmaceutical Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Dong-A Socio Holdings Co Ltd
  • CymaBay Therapeutics Inc
  • Arena Pharmaceuticals Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Glucose Dependent Insulinotropic Receptor Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Glucose Dependent Insulinotropic Receptor Market Size by Region (2021-2032)
  5. 1.4.1 Global Glucose Dependent Insulinotropic Receptor Market Size by Region (2021-2026)
  6. 1.4.2 Global Glucose Dependent Insulinotropic Receptor Market Size by Region (2027-2032)
  7. 1.5 Key Regions Glucose Dependent Insulinotropic Receptor Market Size (2021-2032)
  8. 1.5.1 North America Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (2021-2032)
2 Glucose Dependent Insulinotropic Receptor Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 MBX-2982
  3. 2.1.2 HOB-047
  4. 2.1.3 HD-0471953
  5. 2.1.4 HD-0471042
  6. 2.1.5 GSK-2041706
  7. 2.1.6 DA-1241
  8. 2.1.7 Others
  9. 2.2 Global Glucose Dependent Insulinotropic Receptor Market Size by Type
  10. 2.2.1 Global Glucose Dependent Insulinotropic Receptor Market Size Overview by Type (2021-2032)
  11. 2.2.2 Global Glucose Dependent Insulinotropic Receptor Historic Market Size Review by Type (2021-2026)
  12. 2.2.3 Global Glucose Dependent Insulinotropic Receptor Market Size Forecasted by Type (2027-2032)
  13. 2.3 Global Glucose Dependent Insulinotropic Receptor Market Size by Regions
  14. 2.3.1 North America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026)
  15. 2.3.2 Europe Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026)
  16. 2.3.3 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026)
  17. 2.3.4 South America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026)
  18. 2.3.5 Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Type (2021-2026)
3 Glucose Dependent Insulinotropic Receptor Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Type 2 Diabetes
  3. 3.1.2 Obesity
  4. 3.1.3 Chronic Obstructive Pulmonary Disease (COPD)
  5. 3.1.4 Dyslipidemia
  6. 3.1.5 Others
  7. 3.2 Global Glucose Dependent Insulinotropic Receptor Market Size by Application
  8. 3.2.1 Global Glucose Dependent Insulinotropic Receptor Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Glucose Dependent Insulinotropic Receptor Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Glucose Dependent Insulinotropic Receptor Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Glucose Dependent Insulinotropic Receptor Market Size by Regions
  12. 3.3.1 North America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Glucose Dependent Insulinotropic Receptor Industry Trends
  2. 4.2 Glucose Dependent Insulinotropic Receptor Industry Drivers
  3. 4.3 Glucose Dependent Insulinotropic Receptor Industry Opportunities and Challenges
  4. 4.4 Glucose Dependent Insulinotropic Receptor Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Glucose Dependent Insulinotropic Receptor Revenue (2021-2026)
  2. 5.2 Global Glucose Dependent Insulinotropic Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Glucose Dependent Insulinotropic Receptor Key Company Headquarters & Area Served
  4. 5.4 Global Glucose Dependent Insulinotropic Receptor Company, Product Type & Application
  5. 5.5 Global Glucose Dependent Insulinotropic Receptor Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Glucose Dependent Insulinotropic Receptor Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Glucose Dependent Insulinotropic Receptor Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Glucose Dependent Insulinotropic Receptor Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Co Ltd
  2. 6.1.1 Takeda Pharmaceutical Co Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Co Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Co Ltd Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Glucose Dependent Insulinotropic Receptor Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Merck & Co Inc
  14. 6.3.1 Merck & Co Inc Company Information
  15. 6.3.2 Merck & Co Inc Business Overview
  16. 6.3.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product Portfolio
  18. 6.3.5 Merck & Co Inc Recent Developments
  19. 6.4 GlaxoSmithKline Plc
  20. 6.4.1 GlaxoSmithKline Plc Company Information
  21. 6.4.2 GlaxoSmithKline Plc Business Overview
  22. 6.4.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product Portfolio
  24. 6.4.5 GlaxoSmithKline Plc Recent Developments
  25. 6.5 Amgen Inc
  26. 6.5.1 Amgen Inc Company Information
  27. 6.5.2 Amgen Inc Business Overview
  28. 6.5.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Inc Glucose Dependent Insulinotropic Receptor Product Portfolio
  30. 6.5.5 Amgen Inc Recent Developments
  31. 6.6 Yuhan Corp
  32. 6.6.1 Yuhan Corp Company Information
  33. 6.6.2 Yuhan Corp Business Overview
  34. 6.6.3 Yuhan Corp Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Yuhan Corp Glucose Dependent Insulinotropic Receptor Product Portfolio
  36. 6.6.5 Yuhan Corp Recent Developments
  37. 6.7 Taisho Pharmaceutical Holdings Co Ltd
  38. 6.7.1 Taisho Pharmaceutical Holdings Co Ltd Company Information
  39. 6.7.2 Taisho Pharmaceutical Holdings Co Ltd Business Overview
  40. 6.7.3 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  42. 6.7.5 Taisho Pharmaceutical Holdings Co Ltd Recent Developments
  43. 6.8 Kowa Co Ltd
  44. 6.8.1 Kowa Co Ltd Company Information
  45. 6.8.2 Kowa Co Ltd Business Overview
  46. 6.8.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  48. 6.8.5 Kowa Co Ltd Recent Developments
  49. 6.9 Hyundai Pharmaceutical Co Ltd
  50. 6.9.1 Hyundai Pharmaceutical Co Ltd Company Information
  51. 6.9.2 Hyundai Pharmaceutical Co Ltd Business Overview
  52. 6.9.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  54. 6.9.5 Hyundai Pharmaceutical Co Ltd Recent Developments
  55. 6.10 F. Hoffmann-La Roche Ltd
  56. 6.10.1 F. Hoffmann-La Roche Ltd Company Information
  57. 6.10.2 F. Hoffmann-La Roche Ltd Business Overview
  58. 6.10.3 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  60. 6.10.5 F. Hoffmann-La Roche Ltd Recent Developments
  61. 6.11 Dong-A Socio Holdings Co Ltd
  62. 6.11.1 Dong-A Socio Holdings Co Ltd Company Information
  63. 6.11.2 Dong-A Socio Holdings Co Ltd Business Overview
  64. 6.11.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  66. 6.11.5 Dong-A Socio Holdings Co Ltd Recent Developments
  67. 6.12 CymaBay Therapeutics Inc
  68. 6.12.1 CymaBay Therapeutics Inc Company Information
  69. 6.12.2 CymaBay Therapeutics Inc Business Overview
  70. 6.12.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product Portfolio
  72. 6.12.5 CymaBay Therapeutics Inc Recent Developments
  73. 6.13 Arena Pharmaceuticals Inc
  74. 6.13.1 Arena Pharmaceuticals Inc Company Information
  75. 6.13.2 Arena Pharmaceuticals Inc Business Overview
  76. 6.13.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product Portfolio
  78. 6.13.5 Arena Pharmaceuticals Inc Recent Developments
7 North America
  1. 7.1 North America Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026)
  3. 7.3 North America Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026)
  3. 8.3 Europe Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026)
  3. 10.3 South America Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst